Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
PD158780 shows good therapeutic effect against the A431 epidermoid carcinoma when administered either intraperitoneally or orally
7 nM against HSP90β and of 7
Grossniklaus HE
Incubation of cells with 5 ng/mL SN38 result in cytostasis
TAK-960 (2-1000 nM
BAY-2416964 - CAS# 2242464-44-2 Catalog No.:M7082-2 PD158780 shows good therapeutic effectBAY 2416964, CAS No. 2242464 44 2, is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 192, has an IC50 of 341 nM. BAY2416964 specifically binds to AhR, inhibits AhR activation, and prevents AhR mediated signaling. Abrogation of AhR activation prevents the activation of immune tolerant dendritic cells (DCs) and regulatory T cells (Tregs) in the tumor microenvironment (TME). This may
US$ 35.95
US$ 195.00
US$ 249.97
US$ 417.48